Boosted by cardiovascular disorders and applications, the global market for contrast media is projected to achieve a compound annual growth rate (CAGR) of 4.1% over the next five years, according to a new report from MarketsandMarkets.
At that rate, the worldwide market would reach $5.44 billion by 2021, compared with an estimated $4.46 billion value in 2016.
The cardiovascular segment accounts for the largest share of the global contrast media market, fueled by improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies related to cardiovascular diagnoses, and strong healthcare infrastructure in countries such as the U.S., Canada, the U.K., and Germany.
The microbubble contrast media segment is expected to achieve the greatest CAGR during the forecast period due to ongoing academic studies exploring off-label indications for diagnosis and drug delivery.
